AIgenDrug is proud to announce that Dr. Sunho Lee takes the role of Vice President and Chief Technology Officer (CTO). He will lead the company’s technical strategy and business development for AI drug discovery.
Sunho Lee is an expert in bioinformatics and computer science and received his Ph.D. in Department of Electrical and Computer Engineering from Seoul National University. In his previous role, he led the development of genome mutation analysis algorithms, genome integration platform, and drug biomarker analysis platform. His experience will be at the heart of AIgenDrug's journey to improve human health.
Welcome Dr. Sunho Lee!